How SalioGen's attempt to turn ‘jumping genes’ into medicines fell apart
In the spring of 2022, Ray Tabibiazar summoned his scientists for a pep talk. His startup, SalioGen Therapeutics, had just raised $115 million for a technology dubbed Gene Coding that was framed as a potentially ...
In the spring of 2022, Ray Tabibiazar summoned his scientists for a pep talk. His startup, SalioGen Therapeutics, had just raised $115 million for a technology dubbed Gene Coding that was framed as a potentially ...
